Literature DB >> 15281893

Cannabinoids as neuroprotective agents in traumatic brain injury.

Anat Biegon1.   

Abstract

The name Cannabinoid applies to a large and diverse family of compounds including plant derived, synthetic and endogenously produced chemicals, some but not all of which are psychotropic. Cannabinoids of all classes have the ability to protect neurons from a variety of insults that are believed to underlie delayed neuronal death after traumatic brain injury (TBI), including excitotoxicity, calcium influx, free radical formation and neuroinflammation. The pathways and experimental models supporting a neuroprotective role for the various classes of cannabinoids are critically reviewed vis a vis their potential to support the development of a clinically viable neuroprotective agent for human TBI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15281893     DOI: 10.2174/1381612043384196

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  11 in total

1.  Cannabis and endocannabinoid modulators: Therapeutic promises and challenges.

Authors:  Igor Grant; B Rael Cahn
Journal:  Clin Neurosci Res       Date:  2005

2.  A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain trauma.

Authors:  Sandeep Sharma; Zhe Ying; Fernando Gomez-Pinilla
Journal:  Exp Neurol       Date:  2010-09-15       Impact factor: 5.330

Review 3.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

4.  Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma.

Authors:  S Sharma; Y Zhuang; Z Ying; A Wu; F Gomez-Pinilla
Journal:  Neuroscience       Date:  2009-04-21       Impact factor: 3.590

5.  Exercise facilitates the action of dietary DHA on functional recovery after brain trauma.

Authors:  A Wu; Z Ying; F Gomez-Pinilla
Journal:  Neuroscience       Date:  2013-06-28       Impact factor: 3.590

6.  Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury.

Authors:  Paige S Katz; Jesse K Sulzer; Renata A Impastato; Sophie X Teng; Emily K Rogers; Patricia E Molina
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

7.  Bench to bedside of neural stem cell in traumatic brain injury.

Authors:  Solomon O Ugoya; Jian Tu
Journal:  Stem Cells Int       Date:  2012-09-17       Impact factor: 5.443

8.  Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.

Authors:  Pedro Cunha; Ana M Romão; Filipa Mascarenhas-Melo; Helena M Teixeira; Flávio Reis
Journal:  J Pharm Bioallied Sci       Date:  2011-07

9.  Synthesis of Novel Baicalein Amino Acid Derivatives and Biological Evaluation as Neuroprotective Agents.

Authors:  Xiaohui Jia; Menglu Jia; Yuqin Yang; Di Wang; Fei Zhou; Wenxi Zhang; Xuemei Huang; Wenbo Guo; Desheng Cai; Hongshan Chen; Jinchai Qi; Shuqi Zhou; Haomiao Ren; Bing Xu; Tao Ma; Penglong Wang; Haimin Lei
Journal:  Molecules       Date:  2019-10-09       Impact factor: 4.411

Review 10.  Cannabinoid control of neuroinflammation related to multiple sclerosis.

Authors:  D Baker; S J Jackson; G Pryce
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.